Mayo Clinic’s Regenerative Nephrology Conference is a two-day course that provides attendees with the fundamental principles, tools, and platforms of regenerative nephrology and kidney transplantation, and an overview of how current techniques are applied to provide regenerative solutions to patients. The curriculum includes examples of new technological advances that can facilitate discovery in the field of regenerative nephrology and transplantation. In addition, emerging clinical trials applying stem cells and cell-free extracellular vesicles therapies are highlighted bringing scientific advances to the forefront of individualized patient care.
ARMI| BioFabUSA’s Chief Regulatory Officer, Dr. Richard McFarland will present on the Progress Down the Road(s) to the Realization of the Kidney Health Initiative Renal Replacement Roadmap on Friday, October 21.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
